Aziridine

Aziridine

SCHEMBL5162318

C1CN1.Cc1ncsc1-c1ccnc(Nc2cccc(Cl)c2)n1

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 10/20 0.68
CDK4 P11802 6/20 0.68
CAMK2D Q13557 5/20 0.56
EIF2AK2 P19525 2/20 0.53
ABL1 P00519 1/20 0.52
BCR P11274 1/20 0.52
PRKCA P17252 1/20 0.52
PRKCD Q05655 1/20 0.52
PIK3CA P42336 1/20 0.49
PIK3CB P42338 1/20 0.49
PIK3CG P48736 1/20 0.49
CCNT1 O60563 1/20 0.48
CDK1 P06493 1/20 0.48
CCNB1 P14635 1/20 0.48
CCNA2 P20248 1/20 0.48
CDK7 P50613 1/20 0.48
CDK9 P50750 1/20 0.48
CCNH P51946 1/20 0.48
CCNA1 P78396 1/20 0.48
PLK1 P53350 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6159474 0.81 CDK2 (1.00) CDK2CDK4EIF2AK2CDK1CDK7
SCHEMBL1415012 0.80 CDK2 (0.67) CDK2CDK4CAMK2DABL1PRKCA
SCHEMBL2283009 0.79 CDK2 (0.83) CDK2CDK4CAMK2DEIF2AK2ABL1
SCHEMBL4800928 0.77 CDK2 (0.79) CDK2CDK4CAMK2DABL1BCR
SCHEMBL6157845 0.76 CDK2 (0.78) CDK2CDK4ABL1CCNT1CDK1
SCHEMBL2284099 0.76 CDK2 (0.73) CDK2CDK4CAMK2DEIF2AK2ABL1
SCHEMBL2286433 0.75 CDK2 (0.76) CDK2CDK4CAMK2DEIF2AK2ABL1
SCHEMBL27741372 0.75 CDK2 (0.76) CDK2CDK4CAMK2DEIF2AK2ABL1
SCHEMBL27720262 0.75 CDK2 (0.76) CDK2CDK4CAMK2DEIF2AK2ABL1
SCHEMBL4802694 0.75 CDK2 (0.76) CDK2CDK4CAMK2DEIF2AK2ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1760082-A1 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as anti-proliferative compounds Cyclacel Limited (GB) 2007-03-07 EP disclosed